Frederick G Vogt Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Frederick G Vogt is Interim CEO & General Counsel of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 349,646 shares of IOVA, which is worth approximately $1.08 Million. The most recent transaction as insider was on Apr 14, 2023, when has been sold 20,834 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 350K

58.13% 3M change

147.39% 12M change

Total Value Held $1.08 Million

Frederick G Vogt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 14 2023	BUY Exercise of conversion of derivative security	-	20,834 Added 23.01%	69,718 Common Stock
Jan 17 2023	SELL Payment of exercise price or tax liability	$234,315 $6.43 p/Share	36,441 Reduced 42.71%	48,884 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	83,325 Added 49.41%	85,325 Common Stock
Nov 28 2022	BUY Open market or private purchase	$5,980 $5.98 p/Share	1,000 Added 33.33%	2,000 Common Stock
Jun 01 2022	BUY Open market or private purchase	$6,440 $6.44 p/Share	1,000 Added 50.0%	1,000 Common Stock

FGV

Frederick G Vogt

Interim CEO & General Counsel

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account